First Light Asset Management, LLC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
35 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,115,876,289 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MASS | 908 Devices Inc. | +1,236,377 | 6,072,563 | $37,164,085 | |
| NPCE | NeuroPace Inc | +1,110,484 | 2,459,966 | $32,348,552 | |
| SLP | Simulations Plus, Inc. | +663,906 | 2,632,823 | $31,119,967 | |
| SIBN | SI-BONE, Inc. | +320,286 | 5,353,190 | $67,610,789 | |
| APGE | Apogee Therapeutics, Inc. | +291,693 | 576,684 | $48,539,492 | |
| PVLA | Palvella Therapeutics, Inc. | +271,617 | 980,758 | $122,251,484 | |
| TNDM | Tandem Diabetes Care Inc | +225,222 | 1,314,715 | $25,203,086 | |
| SEPN | Septerna, Inc. | +112,049 | 732,860 | $17,610,625 | |
| IRTC | iRhythm Holdings, Inc. | +14,245 | 168,116 | $19,841,050 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | −1,230,558 | 4,002,768 | $132,611,703 | |
| CNTA | Centessa Pharmaceuticals plc | −717,949 | 1,560,991 | $62,002,562 | |
| EWTX | Edgewise Therapeutics, Inc. | −571,855 | 1,001,846 | $31,558,149 | |
| VERA | Vera Therapeutics, Inc. | −555,770 | 313,906 | $12,628,438 | |
| ATRC | AtriCure, Inc. | −445,924 | 729,521 | $20,813,234 | |
| KRMD | KORU Medical Systems, Inc. | −442,132 | 3,768,380 | $16,279,401 | |
| ORGO | Organogenesis Holdings Inc. | −364,287 | 3,498,533 | $8,291,523 | |
| NEO | Neogenomics Inc | −305,085 | 9,729,978 | $72,196,436 | |
| TWST | Twist Bioscience Corp | −261,923 | 878,848 | $41,762,856 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −208,663 | 87,181 | $7,582,131 | |
| MDXG | Mimedx Group, Inc. | −196,449 | 2,842,892 | $11,229,423 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −164,894 | 3,190,645 | $44,349,965 | |
| BFLY | Butterfly Network, Inc. | −151,964 | 2,660,167 | $10,747,074 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −104,593 | 1,089,670 | $39,576,814 | |
| ANAB | Anaptysbio, Inc | −80,807 | 565,431 | $31,358,774 | |
| ESTA | Establishment Labs Holdings Inc. | −65,344 | 307,738 | $17,473,363 | |
| HCAT | Health Catalyst, Inc. | −32,241 | 12,878,700 | $16,355,949 | |
| GH | Guardant Health, Inc. | −14,452 | 280,299 | $25,891,218 | |
| WVE | Wave Life Sciences Ltd. | −9,883 | 1,843,968 | $13,368,768 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | 5,066,827 | $20,267,308 | |
| TECX | Tectonic Therapeutic, Inc. | 647,743 | $20,021,736 | |
| OMCL | Omnicell, Inc. | 489,846 | $16,351,059 | |
| WGS | GeneDx Holdings Corp. | 242,927 | $15,600,771 | |
| SGP | SpyGlass Pharma, Inc. | 375,000 | $9,716,250 | |
| PCVX | Vaxcyte, Inc. | 141,784 | $8,239,068 | |
| ELVN | Enliven Therapeutics, Inc. | 201,867 | $7,913,186 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 4,002,768 | $132,611,703 | 11.88% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Reduced | 980,758 | $122,251,484 | 10.96% | |
| NEO |
Neogenomics Inc
Healthcare
|
Reduced | 9,729,978 | $72,196,436 | 6.47% | |
| SIBN |
SI-BONE, Inc.
Healthcare
|
Added | 5,353,190 | $67,610,789 | 6.06% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 1,560,991 | $62,002,562 | 5.56% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 576,684 | $48,539,492 | 4.35% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 3,190,645 | $44,349,965 | 3.97% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
Reduced | 878,848 | $41,762,856 | 3.74% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,089,670 | $39,576,814 | 3.55% | |
| MASS |
908 Devices Inc.
Healthcare
|
Added | 6,072,563 | $37,164,085 | 3.33% | |
| NPCE |
NeuroPace Inc
Healthcare
|
Added | 2,459,966 | $32,348,552 | 2.90% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 1,001,846 | $31,558,149 | 2.83% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 565,431 | $31,358,774 | 2.81% | |
| SLP |
Simulations Plus, Inc.
Healthcare
|
Added | 2,632,823 | $31,119,967 | 2.79% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 280,299 | $25,891,218 | 2.32% | |
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
Added | 1,314,715 | $25,203,086 | 2.26% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
Reduced | 729,521 | $20,813,234 | 1.87% | |
| TLSI |
TriSalus Life Sciences, Inc.
Healthcare
|
NEW | 5,066,827 | $20,267,308 | 1.82% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
NEW | 647,743 | $20,021,736 | 1.79% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 168,116 | $19,841,050 | 1.78% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Added | 732,860 | $17,610,625 | 1.58% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Reduced | 307,738 | $17,473,363 | 1.57% | |
| HCAT |
Health Catalyst, Inc.
Healthcare
|
Reduced | 12,878,700 | $16,355,949 | 1.47% | |
| OMCL |
Omnicell, Inc.
Healthcare
|
NEW | 489,846 | $16,351,059 | 1.47% | |
| KRMD |
KORU Medical Systems, Inc.
Healthcare
|
Reduced | 3,768,380 | $16,279,401 | 1.46% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
NEW | 242,927 | $15,600,771 | 1.40% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Reduced | 1,843,968 | $13,368,768 | 1.20% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 313,906 | $12,628,438 | 1.13% | |
| MDXG |
Mimedx Group, Inc.
Healthcare
|
Reduced | 2,842,892 | $11,229,423 | 1.01% | |
| BFLY |
Butterfly Network, Inc.
Healthcare
|
Reduced | 2,660,167 | $10,747,074 | 0.96% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
NEW | 375,000 | $9,716,250 | 0.87% | |
| ORGO |
Organogenesis Holdings Inc.
Healthcare
|
Reduced | 3,498,533 | $8,291,523 | 0.74% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 141,784 | $8,239,068 | 0.74% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 201,867 | $7,913,186 | 0.71% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 87,181 | $7,582,131 | 0.68% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.